13F HOLDINGS REPORT
Foresite Capital Management IV, LLC
Quarter ended Q2 2025 · Filed August 12, 2025 · Accession 0001104659-25-076815
Total Value
$123.8M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Pharvaris N.V. | PHVS | 4,410,581 | $77.6M | 62.70% |
| 2 | Maze Therapeutics Inc | MAZE | 2,111,919 | $25.9M | 20.93% |
| 3 | Lyell Immunopharma, Inc. | LYEL | 800,399 | $7.1M | 5.72% |
| 4 | Xenon Pharmaceuticals Inc | XENE | 160,000 | $5.0M | 4.05% |
| 5 | Kura Oncology, Inc. | KURA | 816,882 | $4.7M | 3.81% |
| 6 | Relay Therapeutics Inc. | RLAY | 1,000,000 | $3.5M | 2.79% |